The treatment management of non-small cell lung cancer has improved significantly in recent years. Innovative treatment options point the way to personalized therapy with fewer side effects and an improved prognosis. In addition, the care structures for seriously ill or elderly patients must not be ignored. Because even there, small supportive measures can lead to a better quality of life.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Compression
Lymphoedema and chronic wounds
- Epilepsy
The treatment of refractory status epilepticus – an overview
- Podiatry support to improve quality of life
Patient mobility with a foot wound
- Rare diseases
Cogan syndrome – a clinical challenge
- Polymyalgia rheumatica and giant cell arteritis
New consensus paper recommends “treat-to-target” strategy
- Threat from Aedes mosquitoes
Dengue, Zika and Chikungunya viruses on the rise
- Systemic lupus erythematosus
DORIS and LLDAS are also worthwhile for severe cases
- Practice Management